CAMBRIDGE DISCOVERY CHEMISTRYä ANNOUNCES THE APPOINTMENT OF NEW VICE PRESIDENT BUSINESS DEVELOPMENT, US

Cambridge, UK… Cambridge Discovery Chemistry Ltd, a wholly owned subsidiary of Oxford Molecular Group Plc (LSE: OMG) today announced the appointment of Lisa Moss as Vice President Business Development, US. Ms Moss will be based at Cambridge Discovery Chemistry’s Western Research Centre, Richmond, California. This appointment strengthens Cambridge Discovery Chemistry’s position in the US, which was firmly established when Cambridge Discovery Chemistry took responsibility for Zeneca’s West Coast chemistry research facility last year. The company now has collaborations in Europe, Japan and the US, making it one of the few global discovery chemistry companies.

Ms Moss joins Cambridge Discovery Chemistry from Pharmaceutical Research Associates, a contract research organisation in the US where, as a senior manager in business development, she implemented strategic business plans resulting in increased market share and revenues for the company.

Prior to her position at Pharmaceutical Research Associates, Ms Moss was a Director of Business Development at Ecova Corp (a subsidiary of AMOCO).

"We are delighted with Lisa’s appointment," Allan Marchington of Cambridge Discovery Chemistry commented. "Her extensive experience of sales and marketing and her network of US contacts will be a true asset to the company and will help us to further develop our commercial position in the US."

 

For further information, please contact:
Cambridge Discovery Chemistry
Allan Marchington, Chief Executive Officer
Tel: +44 1223 722400

Lisa Moss, Vice President, Business Development, US
Tel: +1 916 489 6567

HCC·De Facto Group plc
Chris Gardner, HCC·De Facto Group plc
TEL: +44 171 496 3300

Notes to editors

Cambridge Discovery Chemistry

Cambridge Discovery Chemistry (formerly known as Cambridge Combinatorial Limited) provides world-class, innovative chemistry services to accelerate discovery and process research, servicing the pharmaceutical, agrochemical and biotechnology industries. The Company is a wholly owned subsidiary of Oxford Molecular Group Plc. Cambridge Discovery Chemistry has developed leading technologies for discovery research including innovative molecular design, novel chemistries, new synthetic chemistry platforms and a comprehensive integrated informatics system. The company acts as an extension to the resources of its collaborators with solutions for discovery research including medicinal and combinatorial chemistry for lead generation, validation, optimisation and technology transfer as required.

Cambridge Discovery Chemistry supplies the molecular design and synthesis arm of Oxford Molecular’s Collaborative Discovery. Collaborative Discovery acts as a central point for multi-disciplinary research projects involving both chemistry and biology research. Cambridge Discovery Chemistry has secured many discovery collaborations with a range of pharmaceutical, agrochemical and biotechnology companies spanning the US, Japan and Europe these include: Merck & Co. Inc., Pfizer, Procter & Gamble Pharmaceuticals Inc., Rohm & Haas, Alizyme, Solvay Pharmaceuticals, Mitsubishi Chemical Corporation, Yamanouchi and Fujisawa.

 

Oxford Molecular Group plc

Oxford Molecular is a leading provider of discovery and software solutions to the life sciences market. The Company seeks to deliver excellence in all its products and services and to help its customers benefit from the synergy that is created from the integration of state-of-the-art chemistry, biology and information technology infrastructure. The Discovery Solutions Division offers discovery research through collaboration, by providing world-class innovative technologies in chemistry and biology which intimately match customer needs and add value to their research programmes. The Software Solutions Division supplies enterprise-wide software and information technology solutions for research across the entire drug discovery process. Innovative and superior products target customer needs for excellence in each area of discovery research; and together they form integrated solutions that add value to the flow of information through the customer’s research process. The Company has its headquarters in Oxford, England and has operations throughout the USA as well as sales offices and agents around the world.